Cellromax Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	52,278	73,574	57,231
Market Cap Growth	-12.31%	28.56%	-
Enterprise Value	43,399	68,367	-
Last Close Price	4735.00	6435.26	4704.43
PE Ratio	15.68	24.80	14.99
PS Ratio	2.49	3.32	2.65
PB Ratio	1.10	1.57	1.29
P/TBV Ratio	1.17	1.67	1.39
P/FCF Ratio	25.48	43.11	9.40
P/OCF Ratio	24.55	41.21	9.09
EV/Sales Ratio	2.07	3.08	-
EV/EBITDA Ratio	15.46	20.63	-
EV/EBIT Ratio	18.62	24.11	-
EV/FCF Ratio	21.15	40.06	-
Debt / Equity Ratio	0.01	0.01	0.03
Debt / EBITDA Ratio	0.14	0.14	0.25
Debt / FCF Ratio	0.19	0.28	0.25
Net Debt / Equity Ratio	-0.19	-0.15	-0.48
Net Debt / EBITDA Ratio	-3.16	-2.18	-3.58
Net Debt / FCF Ratio	-4.33	-4.23	-3.49
Asset Turnover	0.42	0.44	-
Inventory Turnover	2.28	2.14	-
Quick Ratio	3.21	3.08	7.41
Current Ratio	4.87	5.20	9.10
Return on Equity (ROE)	7.58%	6.49%	-
Return on Assets (ROA)	2.89%	3.54%	-
Return on Invested Capital (ROIC)	5.94%	7.74%	17.55%
Return on Capital Employed (ROCE)	4.80%	5.90%	12.00%
Earnings Yield	6.54%	4.03%	6.67%
FCF Yield	3.92%	2.32%	10.64%
Payout Ratio	99.15%	114.25%	-
Buyback Yield / Dilution	-6.03%	-9.70%	-